GLP-1RA Exposure and Nonarteritic Anterior Ischemic Optic Neuropathy Prevalence by Diabetes Status
This case-control study examines glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure and prevalence of nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes, obesity, or neither diagnosis.
Authors
- Russell Lee Griffin (ORCID: https://orcid.org/0000-0002-5004-7996)
- Pallavi Nagdeve
Institutions
- University of Alabama (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.2332
- Citations
- 5
- Primary Topic
- Intraoperative Neuromonitoring and Anesthetic Effects
- Type
- article
- Field-Weighted Citation Impact
- 10.03